NIHR Funding Opportunities

The following new funding opportunities are available:

Health Technology Assessment Programme

17/65 – Dequalinium chloride as first-line treatment for bacterial vaginosis
17/66 – Short-term use of benzodiazepines for the acute management of acute low back pain
17/67 – Primary antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis
17/68 – Androgen replacement therapy in symptomatic men with low testosterone
17/69 – Safely and Effectively Stopping Medications in Older People with multimorbidity and polypharmacy
17/71 – Treatment of new onset atrial fibrillation in the ICU
17/72 – Treatment of steroid resistant ulcerative colitis
17/73 – Early reoperation for patients with residual glioblastoma
17/75 – Management of an impacted fetal head during emergency caesarean section
17/76 – Home-blended food for children with gastrostomy tubes
17/77 – Clozapine for children and young people with treatment resistant schizophrenia
17/78 – Physical exercise for depression in adolescents
17/79 – Trauma-focused cognitive behavioural therapy for post-traumatic stress disorder in schizophrenia
17/81 – Recurrent intra-articular corticosteroid injections in osteoarthritis
17/82 – Treatment to target in gout
17/83 – Biological response modifier drugs for rare autoimmune diseases
17/84 – Whole slide imaging in pathology
17/85 – Follow up of quiescent neovascular age-related macular degeneration
17/86 – The clinical and cost effectiveness of screening for Group B Streptococcus (GBS) in pregnancy
17/87 – Proton pump inhibitor therapy for refractory gastro-oesophageal reflux symptoms
17/88 – Fluid resuscitation regimens for burn injuries
17/89 – Interventions for babies born late preterm and early term
17/96 – Benzodiazepines for treatment resistant panic disorder

For more information and a list of all current funding opportunities, please visit the NIHR website.

Tagged with

Published on 9. August 2017 in News UK